It's war: Oracle vs. SAP -- let the games begin


Oracle Corp. (NASDAQ:ORCL) has filed suit against giant German software company and its number one rival SAP AG (NYSE:SAP). This is going to be interesting as the details unfold. The suit was filed in U.S. District court in San Francisco, Oracle's backyard. Oracle claims that SAP used mutual customers' password codes to enter the Oracle's main web support site to steal and download software code.

This is almost funny and really does not make much sense:

The mega applications company SAP has been the undisputed worldwide leader in business applications, from HR applications to financial applications to business processes applications. SAP is renowned for its superior research and development work and innovation of its product set from the inside. Oracle, on the other hand, is the undisputed leader in database software, world-wide, and very mediocre when it comes to the applications business.

Oracle's past ten years of research and development efforts have been so dismal that the company had to resort to many acquisitions to fill the gap. Oracle has spent $20 billion on 30 different acquisitions the past three years. It is certainly making in-roads compared to SAP in the applications business, but it is still in a distant second place.

Oracle has never been known for its customer service. SAP is renowned for its customer service. This is what makes this suit so interesting. This may be Oracle's attempt to "freeze" the market place for awhile as was a common practice back in the 1990s when competing software firms would sue each other claiming stolen software code.

The whole new legal arena of "intellectual property" is interesting. When one engineer leaves a company to join a rival, does the software configuration code in his head belong to him or to his previous employer? It's a matter of interpretation and what the judge is listening.

The medical device industry is also renown for its law suits and counter-suits: Medtronic Inc. (NYSE:MDT) Vs. St.Jude Medical Inc. (NYSE:STJ), St. Jude vs. Boston Scientific Corp.'s (NYSE:BSX) Guidant etc. It typically froze the market as customers do not want to align themselves with one side or the other or take sides during a dispute.

Oracle has thrown down the gauntlet. The ensuing details will be fascinating to watch. Stay tuned.

Georges Yared is the author of "Stop Losing Money Today" and "Baby Boomer Investing" Please visit www.georgesyared.com

Reader Comments (Page 1 of 1)

Symbol Lookup
IndexesChangePrice
DJIA-89.2312,801.23
NASDAQ-23.352,903.88
S&P 500-9.311,342.64

Last updated: February 12, 2012: 03:21 PM

Hot Stocks

General Electric

18.875-0.255(-1.33)

Alcoa

10.29-0.35(-3.29)

Apple Inc

493.42+0.25(+0.05)

Google Inc 'A'

605.91-5.55(-0.91)

Bank of America

8.07-0.11(-1.34)

Wal-Mart Stores

61.90-0.06(-0.10)

Exxon Mobil Corp

83.80-1.08(-1.27)

Ford

12.44-0.25(-1.97)

Citigroup

32.925-0.735(-2.18)

IBM

192.42-0.71(-0.37)

Yahoo

16.14+0.14(+0.88)

Starbucks

48.82-0.38(-0.77)

Microsoft

30.495-0.275(-0.89)

Home Depot

45.33+0.06(+0.13)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1329078110289 ms.